Resources

Behind every deviation, dozens of small warnings went unnoticed. How to capture and handle weak signals simply, to move from reactive to proactive Quality.

People jumping from one topic to another, meetings piling up, the medium term always sacrificed. Why a team loses capacity, and how to align it with its processes to do more with the same people.

“Human error” is often the conclusion of an investigation, when it is a symptom. Why reminders of the rules and extra checks don’t work, and how to find the real causes.

Sending every batch record back to production for a minor correction takes ten times longer, weakens data integrity and demotivates teams. How to correct directly, with clear rules and rigorous traceability.

A reassuring average release lead time can hide batches waiting for weeks. Box plots, FIFO and bottlenecks: three keys to understanding your release flow and making it reliable.

Checking that a CAPA has been implemented doesn’t prove it is effective. Which CAPAs to assess, how to define effectiveness from the design stage, and what to do with an ineffective CAPA.

Electronic batch record: how to succeed with EBR digitalisation, make traceability reliable, reduce errors and speed up batch review in the pharmaceutical industry.

Releasing a batch, classifying a deviation, choosing a CAPA: our quality decisions go through mental shortcuts. The 7 most common cognitive biases in the pharmaceutical industry, and how to protect yourself from them.

Quality culture in the pharmaceutical industry isn’t just posters or successful audits. The 4 maturity levels (Endure, Defend, Master, Anticipate) and why Lean or “right first time” are useless without a solid cultural foundation.

Every quality professional dreams of right first time. But is it the real marker of a strong quality culture on a pharmaceutical site? Why you need to move from reactive to proactive Quality, and where to start.

The description of the change carries everything in change control. Why describing a change is a skill, how to assess it in committee (impacts, risks, effort) and why it must be managed through to closure.

Tick boxes, signatures at every step, double checks: checklists are reassuring, but they end up being filled in mechanically. When they really protect, when they do harm, and how to make errors visible.

Endless indicators, meetings that overrun, actions never followed up. The simple rules of visual management that works: a well-designed board, short rituals and clear operating rules.

Observing a task seems simple. Yet, done badly, task observation becomes a disguised audit that puts teams on the defensive. How to prepare it, carry it out and turn it into concrete improvements.